Literature DB >> 14190860

POLIOVIRUS VACCINES AND THE CONTROL OF POLIOMYELITIS.

C H STUART-HARRIS.   

Abstract

Entities:  

Keywords:  AUSTRALIA; GREAT BRITAIN; NEW ZEALAND; POLIOVIRUS VACCINE; POLIOVIRUS VACCINE, ORAL; STATISTICS; UNITED STATES

Mesh：

Substances：

Year:  1964        PMID： 14190860      PMCID： PMC1898038     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  9 in total

1.  THE CUTTER INCIDENT. POLIOMYELITIS FOLLOWING FORMALDEHYDE- INACTIVATED POLIOVIRUS VACCINATION IN THE UNITED STATES DURING THE SPRING OF 1955. I. BACKGROUND.

Authors:  N NATHANSON; A D LANGMUIR
Journal:  Am J Hyg       Date:  1963-07

2.  Induction of malignancy in vitro in newborn hamster kidney tissue infected with simian vacuolating virus (SV40).

Authors:  A S RABSON; R L KIRSCHSTEIN
Journal:  Proc Soc Exp Biol Med       Date:  1962-11

3.  An evaluation of the carcinogenicity of simian virus 40 in man.

Authors:  J F FRAUMENI; F EDERER; R W MILLER
Journal:  JAMA       Date:  1963-08-31       Impact factor: 56.272

4.  Vaccination against poliomyelitis with live virus vaccines. 7. Effect of previous Salk vaccination on virus excretion.

Authors:  G W DICK; D S DANE; J McALISTER; M BRIGGS; R NELSON; C M FIELD
Journal:  Br Med J       Date:  1961-07-29

5.  The vacuolating virus, S.V. 40.

Authors:  B H SWEET; M R HILLEMAN
Journal:  Proc Soc Exp Biol Med       Date:  1960-11

6.  Vacuolating agent.

Authors:  D I MAGRATH; K RUSSELL; J O TOBIN
Journal:  Br Med J       Date:  1961-07-29

7.  The quantitation of poliomyelitis virus in the human alimentary tract with reference to coexisting levels of homologous serum neutralizing antibody.

Authors:  H A HOWE
Journal:  Am J Hyg       Date:  1962-01

8.  Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine.

Authors:  J L MELNICK; S STINEBAUGH
Journal:  Proc Soc Exp Biol Med       Date:  1962-04

9.  Clinical and serologic responses in volunteers given vacuolating virus (SV-40) by respiratory route.

Authors:  J A MORRIS; K M JOHNSON; C G AULISIO; R M CHANOCK; V KNIGHT
Journal:  Proc Soc Exp Biol Med       Date:  1961-10
  9 in total
  3 in total

1.  SURVEILLANCE OF THE SAFETY OF ORAL POLIOMYELITIS VACCINE IN ENGLAND AND WALES 1962-4.

Authors:  D L MILLER; N S GALBRAITH
Journal:  Br Med J       Date:  1965-08-28

2.  Polio-virus vaccines--an iota of risk?

Authors:  R K Chandra
Journal:  Indian J Pediatr       Date:  1965-10       Impact factor: 1.967

3.  Paralytic poliomyelitis in Norway since the introduction of trivalent oral vaccine: an epidemiological and virological study.

Authors:  I Orstavik; L B Flugsrud; O Lahelle
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.